Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active‐Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk ( ARCH) trial

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update

(2020) Dolores Shoback et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS— 2020 UPDATE EXECUTIVE SUMMARY

(2020) Pauline M. Camacho et al.   Endocrine Practice

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline

(2019) Richard Eastell et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials

(2019) Mary L Bouxsein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone Mechanical Properties in Healthy and Diseased States

(2018) Elise F. Morgan et al.   Annual Review of Biomedical Engineering

Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study

(2018) Michael R McClung et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab

(2018) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

(2018) David L Kendler et al.   LANCET

Prediction of incident vertebral fracture using CT-based finite element analysis

(2018) B. T. Allaire et al.   OSTEOPOROSIS INTERNATIONAL

Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass

(2017) Tony M Keaveny et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

(2017) Bente L Langdahl et al.   LANCET

Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis

(2017) Felicia Cosman et al.   MAYO CLINIC PROCEEDINGS

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

(2017) Kenneth G. Saag et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vertebral Fractures: Clinical Importance and Management

(2016) D.L. Kendler et al.   AMERICAN JOURNAL OF MEDICINE

Bone mechanical properties and changes with osteoporosis

(2016) Georg Osterhoff et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

Finite Element Analysis of Denosumab Treatment Effects on Vertebral Strength in Ovariectomized Cynomolgus Monkeys

(2016) David C Lee et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass

(2016) Harry K Genant et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

(2016) Felicia Cosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years

(2015) S. Ferrari et al.   OSTEOPOROSIS INTERNATIONAL

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

(2014) Michael R. McClung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab

(2013) Tony M Keaveny et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Microstructural Failure Mechanisms in the Human Proximal Femur for Sideways Fall Loading

(2013) Shashank Nawathe et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans

(2013) David L Kopperdahl et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

(2011) Matthew Austin et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Biomechanical computed tomography-noninvasive bone strength analysis using clinical computed tomography scans

(2010) Tony M. Keaveny   Annals of the New York Academy of Sciences

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

(2010) Desmond Padhi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Influence of vertical trabeculae on the compressive strength of the human vertebra

(2010) Aaron J Fields et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Which fractures are most attributable to osteoporosis?

(2010) Amy H. Warriner et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial

(2009) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Quantifying the material and structural determinants of bone strength

(2009) Mary L. Bouxsein et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Reanalysis precision of 3D quantitative computed tomography (QCT) of the spine

(2008) Klaus Engelke et al.   BONE

Once-Monthly Oral Ibandronate Improves Biomechanical Determinants of Bone Strength in Women with Postmenopausal Osteoporosis

(2008) E. Michael Lewiecki et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM